FDA NDC Directory · JSON-LD · Markdown

COSELA

NDC 73462-101 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nametrilaciclib
Labeler / ManufacturerG1 Therapeutics, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA214200
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTRILACICLIB DIHYDROCHLORIDE (300 mg/20mL)
Marketing started20210212
Marketing ended20281231
Package count1

External sources

Source: openFDA. Public-domain (CC0).